Metabolomics analysis in saliva from periodontally healthy, gingivitis and periodontitis patients.
NMR
gingivitis
markers
metabolites
periodontitis
saliva
Journal
Journal of periodontal research
ISSN: 1600-0765
Titre abrégé: J Periodontal Res
Pays: United States
ID NLM: 0055107
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
29
08
2023
received:
11
05
2023
accepted:
01
09
2023
medline:
15
11
2023
pubmed:
3
10
2023
entrez:
3
10
2023
Statut:
ppublish
Résumé
The aim of this study was to investigate metabolomics markers in the saliva of patients with periodontal health, gingivitis and periodontitis. The use of metabolomics for diagnosing and monitoring periodontitis is promising. Although several metabolites have been reported to be altered by inflammation, few studies have examined metabolomics in saliva collected from patients with different periodontal phenotypes. Saliva samples collected from a total of 63 patients were analysed by nuclear magnetic resonance (NMR) followed by ELISA for interleukin (IL)-1β. The patient sample, well-characterised clinically, included periodontal health (n = 8), gingivitis (n = 19) and periodontitis (n = 36) cases, all non-smokers and not diabetic. Periodontal diagnosis (healthy/gingivitis/periodontitis) was not associated with any salivary metabolites in this exploratory study. Periodontal staging showed nominal associations with acetoin (p = .030) and citrulline (p = .047). Among other investigated variables, the use of systemic antibiotics in the previous 3 months was associated with higher values of the amino acids taurine, glycine and ornithine (p = .002, p = .05 and p = .005, respectively, at linear regression adjusted for age, gender, ethnicity, body mass index and staging). While periodontal staging was marginally associated with some salivary metabolites, other factors such as systemic antibiotic use may have a much more profound effect on the microbial metabolites in saliva. Metabolomics in periodontal disease is still an underresearched area that requires further observational studies on large cohorts of patients, aiming to obtain data to be used for clinical translation.
Sections du résumé
OBJECTIVE
OBJECTIVE
The aim of this study was to investigate metabolomics markers in the saliva of patients with periodontal health, gingivitis and periodontitis.
BACKGROUND
BACKGROUND
The use of metabolomics for diagnosing and monitoring periodontitis is promising. Although several metabolites have been reported to be altered by inflammation, few studies have examined metabolomics in saliva collected from patients with different periodontal phenotypes.
METHODS
METHODS
Saliva samples collected from a total of 63 patients were analysed by nuclear magnetic resonance (NMR) followed by ELISA for interleukin (IL)-1β. The patient sample, well-characterised clinically, included periodontal health (n = 8), gingivitis (n = 19) and periodontitis (n = 36) cases, all non-smokers and not diabetic.
RESULTS
RESULTS
Periodontal diagnosis (healthy/gingivitis/periodontitis) was not associated with any salivary metabolites in this exploratory study. Periodontal staging showed nominal associations with acetoin (p = .030) and citrulline (p = .047). Among other investigated variables, the use of systemic antibiotics in the previous 3 months was associated with higher values of the amino acids taurine, glycine and ornithine (p = .002, p = .05 and p = .005, respectively, at linear regression adjusted for age, gender, ethnicity, body mass index and staging).
CONCLUSION
CONCLUSIONS
While periodontal staging was marginally associated with some salivary metabolites, other factors such as systemic antibiotic use may have a much more profound effect on the microbial metabolites in saliva. Metabolomics in periodontal disease is still an underresearched area that requires further observational studies on large cohorts of patients, aiming to obtain data to be used for clinical translation.
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1272-1280Informations de copyright
© 2023 The Authors. Journal of Periodontal Research published by John Wiley & Sons Ltd.
Références
Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016;6(1):66-75.
Biyikoğlu B, Ricker A, Diaz PI. Strain-specific colonization patterns and serum modulation of multi-species oral biofilm development. Anaerobe. 2012;18(4):459-470.
Hannig C, Hannig M, Attin T. Enzymes in the acquired enamel pellicle. Eur J Oral Sci. 2005;113(1):2-13.
Hannig C, Hannig M, Kensche A, Carpenter G. The mucosal pellicle - an underestimated factor in oral physiology. Arch Oral Biol. 2017;80:144-152.
Keijser BJ, Zaura E, Huse SM, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res. 2008;87(11):1016-1020.
Marsh PD, Do T, Beighton D, Devine DA. Influence of saliva on the oral microbiota. Periodontol 2000. 2000;70:80-92.
Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life. 2009;2(3):303-307.
Dame ZT, Aziat F, Mandal R, et al. The human saliva metabolome. Metabolomics. 2015;11(6):1864-1883.
Gardner A, Carpenter G, So PW. Salivary metabolomics: from diagnostic biomarker discovery to investigating biological function. Metabolites. 2020;10(2):47.
Gardner A, Parkes HG, So PW, Carpenter GH. Determining bacterial and host contributions to the human salivary metabolome. J Oral Microbiol. 2019;11(1):1617014.
Pereira JL, Duarte D, Carneiro TJ, et al. Saliva NMR metabolomics: analytical issues in pediatric oral health research. Oral Dis. 2019;25(6):1545-1554.
Wallner-Liebmann S, Tenori L, Mazzoleni A, et al. Individual human metabolic phenotype analyzed by (1) H NMR of saliva samples. J Proteome Res. 2016;15(6):1787-1793.
Tsuchida S, Nakayama T. Metabolomics research in periodontal disease by mass spectrometry. Molecules. 2022;27(9):2864.
Deo PN, Deshmukh R. Oral microbiome: unveiling the fundamentals. J Oral Maxillofac Pathol. 2019;23(1):122-128.
Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745-759.
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44.
Arias-Bujanda N, Regueira-Iglesias A, Balsa-Castro C, Nibali L, Donos N, Tomás I. Accuracy of single molecular biomarkers in saliva for the diagnosis of periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(1):2-18.
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun. 2004;5(5):315-329.
Karimbux NY, Saraiya VM, Elangovan S, et al. Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: a systematic review and meta-analysis. J Periodontol. 2012;83(11):1407-1419.
Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000. 2000;1997(14):33-53.
Kelk P, Claesson R, Hänström L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun. 2005;73(1):453-458.
Kelk P, Johansson A, Claesson R, Hänström L, Kalfas S. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun. 2003;71(8):4448-4455.
Cheng R, Wu Z, Li M, Shao M, Hu T. Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review. Int J Oral Sci. 2020;12(1):2.
Faizuddin M, Bharathi SH, Rohini NV. Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res. 2003;38(2):111-114.
Sánchez GA, Miozza VA, Delgado A, Busch L. Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment. J Clin Periodontol. 2013;40(12):1112-1117.
Isaza-Guzmán DM, Medina-Piedrahíta VM, Gutiérrez-Henao C, Tobón-Arroyave SI. Salivary levels of NLRP3 Inflammasome-related proteins as potential biomarkers of periodontal clinical status. J Periodontol. 2017;88(12):1329-1338.
Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD. Periodontal disease at the biofilm-gingival interface. J Periodontol. 2007;78(10):1911-1925.
Sağlam M, Köseoğlu S, Taşdemir I, Erbak Yılmaz H, Savran L, Sütçü R. Combined application of Er:YAG and Nd:YAG lasers in treatment of chronic periodontitis. A split-mouth, single-blind, randomized controlled trial. J Periodontal Res. 2017;52(5):853-862.
Tsang YC, Corbet EF, Jin LJ. Subgingival glycine powder air-polishing as an additional approach to nonsurgical periodontal therapy in subjects with untreated chronic periodontitis. J Periodontal Res. 2018;53(3):440-445.
Baima G, Corana M, Iaderosa G, et al. Metabolomics of gingival crevicular fluid to identify biomarkers for periodontitis: a systematic review with meta-analysis. J Periodontal Res. 2021;56(4):633-645.
Tzimas K, Pappa E. Saliva Metabolomic profile in dental medicine research: a narrative review. Metabolites. 2023;13(3):379.
Guerrero A, Griffiths GS, Nibali L, et al. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2005;32(10):1096-1107.
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229-235.
Laster L, Laudenbach KW, Stoller NH. An evaluation of clinical tooth mobility measurements. J Periodontol. 1975;46(10):603-607.
Hamp SE, Nyman S, Lindhe J. Periodontal treatment of multirooted teeth. Results after 5 years. J Clin Periodontol. 1975;2(3):126-135.
Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and Peri-implant diseases and conditions. J Clin Periodontol. 2018;45:S162-s170.
Chapple ILC, Mealey BL, Van Dyke TE, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and Peri-implant diseases and conditions. J Periodontol. 2018;89:S74-s84.
Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45:S1-s8.
Bartlett D, Ganss C, Lussi A. Basic erosive Wear examination (BEWE): a new scoring system for scientific and clinical needs. Clin Oral Investig. 2008;12(Suppl 1):S65-S68.
Citterio F, Romano F, Meoni G, et al. Changes in the salivary metabolic profile of generalized periodontitis patients after non-surgical periodontal therapy: a Metabolomic analysis using nuclear magnetic resonance spectroscopy. J Clin Med. 2020;9(12):3977.
Cesselin B, Henry C, Gruss A, Gloux K, Gaudu P. Mechanisms of acetoin toxicity and adaptive responses in an acetoin-producing species, Lactococcus lactis. Appl Environ Microbiol. 2021;87(24):e0107921.
Uğar-Cankal D, Ozmeric N. A multifaceted molecule, nitric oxide in oral and periodontal diseases. Clin Chim Acta. 2006;366(1-2):90-100.
McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67(7):3248-3256.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134-144.
Matejka M, Partyka L, Ulm C, Solar P, Sinzinger H. Nitric oxide synthesis is increased in periodontal disease. J Periodontal Res. 1998;33(8):517-518.
Brito F, Curcio HFQ, da Silva Fidalgo TK. Periodontal disease metabolomics signatures from different biofluids: a systematic review. Metabolomics. 2022;18(11):83.
Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision nutrition and the microbiome, part I: current state of the science. Nutrients. 2019;11(4):923.
Dubourg G, Lagier JC, Robert C, et al. Culturomics and pyrosequencing evidence of the reduction in gut microbiota diversity in patients with broad-spectrum antibiotics. Int J Antimicrob Agents. 2014;44(2):117-124.
Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature. 2011;476(7361):393-394.
Ready D, Lancaster H, Qureshi F, Bedi R, Mullany P, Wilson M. Effect of amoxicillin use on oral microbiota in young children. Antimicrob Agents Chemother. 2004;48(8):2883-2887.
Wade WG. Resilience of the oral microbiome. Periodontol 2000. 2000;86:113-122.
Ferrer M, Méndez-García C, Rojo D, Barbas C, Moya A. Antibiotic use and microbiome function. Biochem Pharmacol. 2017;134:114-126.
Pérez-Cobas AE, Artacho A, Knecht H, et al. Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PloS One. 2013;8(11):e80201.
Pitts NB, Zero DT, Marsh PD, et al. Dental caries. Nat Rev Dis Primers. 2017;3:17030.
Takahashi N. Microbial ecosystem in the oral cavity: metabolic diversity in an ecological niche and its relationship with oral diseases. Int Congr Ser. 2005;1284:103-112.
Fidalgo TKS, Freitas-Fernandes LB, Angeli R, et al. Salivary metabolite signatures of children with and without dental caries lesions. Metabolomics. 2012;9:657-666.
Fidalgo TKS, Freitas-Fernandes LB, Almeida FCL, Valente AP, Souza IPR. Longitudinal evaluation of salivary profile from children with dental caries before and after treatment. Metabolomics. 2014;11:583-593.
Sengupta A, Uppoor A, Joshi MB. Metabolomics: paving the path for personalized periodontics - a literature review. J Indian Soc Periodontol. 2022;26(2):98-103.
Hyvärinen E, Savolainen M, Mikkonen JJW, Kullaa AM. Salivary metabolomics for diagnosis and monitoring diseases: challenges and possibilities. Metabolites. 2021;11(9):587.
Wishart DS. Advances in metabolite identification. Bioanalysis. 2011;3(15):1769-1782.
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332-1345.
Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18(5):968-984.
Logan AC, Jacka FN, Prescott SL. Immune-microbiota interactions: Dysbiosis as a Global Health issue. Curr Allergy Asthma Rep. 2016;16(2):13.
Yao Y, Cai X, Fei W, Ye Y, Zhao M, Zheng C. The role of short-chain fatty acids in immunity, inflammation and metabolism. Crit Rev Food Sci Nutr. 2022;62(1):1-12.
Cho SS, Qi L, Fahey GC Jr, Klurfeld DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013;98(2):594-619.
Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22(9):849-855.
Armitage GC. The complete periodontal examination. Periodontol 2000. 2000;2004:22-33.
Armitage GC. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000. 2000;2010:70-88.
Almeida PA, Fidalgo TKS, Freitas-Fernandes LB, Almeida FCL, Souza IPR, Valente AP. Salivary metabolic profile of children and adolescents after hemodialysis. Metabolomics. 2017;13:1-10.
de Oliveira LR, Martins C, Fidalgo TK, et al. Salivary metabolite fingerprint of type 1 diabetes in young children. J Proteome Res. 2016;15(8):2491-2499.
Nguyen T, Sedghi L, Ganther S, Malone E, Kamarajan P, Kapila YL. Host-microbe interactions: profiles in the transcriptome, the proteome, and the metabolome. Periodontol 2000. 2000;82(1):115-128.